<DOC>
	<DOCNO>NCT00806403</DOCNO>
	<brief_summary>The main objective compare fibrinolytic strategy interventional strategy initiate early possible , preferably pre-hospital phase , respect resolution ST-segment elevation 120 minute inclusion Thrombolysis In Myocardial Infarction ( TIMI ) flow grade evaluate mandated coronary angiography 5 7 day inclusion .</brief_summary>
	<brief_title>Comparison Between Thrombolysis Primary Percutaneous Coronary Intervention ( PCI ) Treat ST-Segment Elevation Myocardial Infarction</brief_title>
	<detailed_description>Patients fibrinolytic group receive intravenous injection 30 mg enoxaparin follow subcutaneous injection 1 mg/kg body weight every 12 hour hospital stay . Patients invasive group give intravenous injection enoxaparin ( 0.75 mg/kg body weight ) abciximab intravenous bolus ( 0.25 mg/kg body weight ) follow 12 hour infusion ( 10 microg/minute ) . Secondary outcome measure death , myocardial infarction stroke alone composite 30 day . Data use health care resource , loss production health-related quality life collect one year . Cost-effectiveness determine compare cost quality-adjusted survival .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Abciximab</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Reteplase</mesh_term>
	<criteria>Patients present within 6 h onset chest pain last 30 min significant STsegment elevation ECG . BP &gt; 180/110 Known bleed disorder Cardiogenic shock CPR &gt; 10 min Ongoing anticoagulant therapy Renal insufficiency Weight &gt; 120 kg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>thrombolysis</keyword>
	<keyword>primary PCI</keyword>
	<keyword>abciximab</keyword>
	<keyword>ST-segment resolution</keyword>
	<keyword>TIMI flow</keyword>
</DOC>